NLRP3 and metabolic dysfunction-associated steatohepatitis: GSDMD is widely considered an inflammatory caspase-mediated pore-forming effector protein during pyroptotic cell death, and increases in NLRP3-GSDMD levels have been observed in patients with NASH (7, 8, 9).